The Geisinger Board of Directors recently appointed Dr. Terry Gilliland to be president of Geisinger Health.
He was also appointed CEO to replace Dr. Jaewon Ryu who will become CEO of Risant Health.
“On behalf of the entire board of directors, I am thrilled to welcome Terry Gilliland to Geisinger,” Heather Acker, Geisinger board of directors chairwoman, said. “The board executed an extensive national search before coming to this decision. The role of leading Geisinger is unique. It requires passion for our mission — to make better health easier for our patients and members across Pennsylvania; a drive to innovate care delivery; and a commitment to educating future caregivers. We are confident that Dr. Gilliland is the right person to lead Geisinger on our path forward.”
Gilliland previously served as Cogitativo chief medical officer and chief science officer, as Blue Shield of California executive vice president of healthcare quality and affordability, as Sentara Healthcare senior vice president and chief medical officer, and held several leadership roles at the Mid-Atlantic Permanente Medical Group and the Colorado Permanente Medical Group within Kaiser Permanente.
Geisinger’s system includes 10 hospital campuses, a research institute and the Geisinger College of Health Sciences, and a health plan with more than 500,000 members.